definiens: means any enhancement, improvement or modification ( each, an ) to the Licensed IntellectualProperty that is ( a ) an Improvement to the composition of or methods of making anyCytotoxic Compound, ( b ) an Improvement to the conjugation process for making ADCs orPDCs ( including, for example, reaction conditions or changes in process that createimprovements in the yield of such conjugate ), ( c ) an Improvement to the composition of ormethods for making Linkers, ( d ) an Improvement to any of the analytical methods used formaking, releasing and characterizing any Cytotoxic Compound, Linker, ADCs or PDCs, or ( e ) an Improvement to the formulation of ADCs or PDCs . Licensed Products, in and ofthemselves, will not be deemed to be TAP Platform Improvements, although the Partiesacknowledge that TAP Platform Improvements may be incorporated into LicensedProducts